4//SEC Filing
Ryan Charles S. 4
Accession 0001415889-24-022054
CIK 0001662774other
Filed
Aug 21, 8:00 PM ET
Accepted
Aug 22, 5:51 PM ET
Size
5.2 KB
Accession
0001415889-24-022054
Insider Transaction Report
Form 4
Ryan Charles S.
President
Transactions
- Purchase
Common Stock
2024-08-20$0.65/sh+48,387$31,452→ 122,461 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.62 to $0.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Documents
Issuer
Quince Therapeutics, Inc.
CIK 0001662774
Entity typeother
Related Parties
1- filerCIK 0001624830
Filing Metadata
- Form type
- 4
- Filed
- Aug 21, 8:00 PM ET
- Accepted
- Aug 22, 5:51 PM ET
- Size
- 5.2 KB